News Center

• 2022.03.21Grandway advised SINENG (300827) IPO on GEM of Shenzhen Stock Exchange on April 10, 2020
• 2022.03.21Grandway advised Rockchip Electronics Co., Ltd. (603893) IPO on the Main Board of Shanghai Stock Exchange on February 7, 2020
• 2021.08.23Grandway Advised Konruns Pharmaceutical on its Series-D Fundraising of Nuance Biotech
• 2021.08.23Grandway Advised Yantai China Pet Foods on its acquisition of PetfoodNZ
• 2020.05.19Grandway Advised UPL on its Acquisition of Laoting Yoloo
• 2020.03.12Grandway won the 2020 China Law Awards (Securities & Capital Markets: Onshore Issuance Law Firm of the Year) by LEGALBAND
• 2019.11.12Seminar on Chinese Investment & Acquisition in Brazil
• 2019.11.12Grandway ranks in the lists of Chambers 2019
• 2019.08.12Grandway’s Awards in 2019
• 2019.07.12Grandway Assist CCB & Exim Bank on Cross-border Syndicated Loan Project
• 2019.04.12Grandway joined the vice chairman rank to launch “Foreign M&A Work Committee” under Ministry of Commerce
• 2019.04.12David Zou Spoke at a Cyber Security & Compliance Summit
• 2019.01.15Grandway advised the public issuance of convertible bond of China Nuclear Engineering&Construction Group Corporation Limited (Stock Code:601611) which received approval of CRSC on January 15, 2019.
• 2019.01.12Grandway assists the client to win a administrative litigation case with Wanning municipal government regarding the disputes of expropriation of land use right.
• 2019.01.12Grandway assists the client that being accused for insider trading to receive the positive result in such insider trading case.
• 2019.01.12Grandway’s two sucessful cases was granted as “Leading Public Legal Service Projects”
• 2019.01.11Grandway assists the client to win a administrative litigation case with Wanning municipal government regarding the disputes of expropriation of land use right.
• 2019.01.11Grandway advised the public issuance of 2 billions renewable corporate bond of China Nuclear Engineering&Construction Group Corporation Limited (Stock Code:601611) on Janauray 11,
• 2018.12.29Grandway advised the private placement of Anhui Genuine New Materials Co.,Ltd. (Stock Code:603429) which received approval of CRSC on December 24, 2018.
• 2018.12.28Grandway advised Jiangxi Fushine Pharmaceutical Co., Ltd.(Stock Code:300497) on its issuance of convertible corporate bond on Shenzhen Stock Exchange which received the approval from CSRC on December